An independent, nonprofit research institute
©2010 SRI International
Privacy policy
Late-Stage Breast Cancer Drug Advancing to Clinical Development
SRI is furthering development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd.
- Results of 21st Century Community Learning Centers Study Released
- Meet the 2010 SRI Fellows
- SRI's CEO Named to National Advisory Council on Innovation
Podcast:
Pablo Garcia, Medical Robotics Engineer, on Critical Need for New Medical Devices for Pediatric Use- Twins Needed for New Flu Vaccine Study
- SRI and BRS Labs to Provide Integrated Security Solutions for Public Safety Organizations
Connect
|
||||||||
Ken Augustyn, Assistant Director, SRI Ann Arbor |
Meeting important needs of government, business, and foundations |
Technology transfer for new opportunities |
Creating market value |
Creating compelling value for organizations and customers |
SRI has created new industries, markets, and benefits to society |
Some of our latest innovations |
||
 |
 |
 |
 |
 |
 |
|||
